Roche
Actemra/RoActemra (tocilizumab)
Actemra/RoActemra is approved in 116 countries for the treatment of rheumatoid arthritis (RA)
Alecensa (alectinib)
Alecensa is a highly selective, central nervous system-active
Avastin (bevacizumab)
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A)
Copegus (ribavarin)
Copegus is an antiviral medication that, in combination with other medicinal products
Cotellic (cobimetinib)
Cotellic is a kinase inhibitor indicated for the treatment of patients with BRAF V600E or BRAF V600K mutation-positive advanced melanoma
Enspryng (satralizumab)
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A)
Erivedge (vismodegib)
Erivedge is a capsule taken once-daily to treat adults with a type of skin cancer
Esbriet (pirfenidone)
Esbriet is an oral anti-fibrotic medicine approved for the treatment of Idiopathic Pulmonary Fibrosis (IPF)
Fuzeon (enfuvirtide)
Fuzeon is an HIV fusion inhibitor, which blocks HIV’s ability to infect healthy CD4+ T cells
Perjeta (pertuzumab)
Perjeta is a medicine that targets the HER2 receptor, a protein found on the outside of many normal cells